Artivion Receives FDA Approval for Aortic Arch System

Artivion, Inc. has announced U.S. FDA approval for its NEXUS® Aortic Arch System, a significant development for the company specializing in cardiac and vascular surgery. This approval allows for the commercialization of a new device aimed at treating aortic disease, a critical area in cardiovascular medicine. The NEXUS system is expected to enhance treatment options for patients suffering from complex aortic conditions, reinforcing Artivion's position in the medical device sector.